Skip to main content
Premium Trial:

Request an Annual Quote

Genomic Health Signs Up Oncotype DX Distributor for Spain, Portugal

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genomic Health today said that it has reached an exclusive agreement with Palex Medical to distribute the firm's Oncotype DX breast cancer test in Spain and Portugal.

The Redwood City, Calif.-based pharmacogenomics firm said that the agreement will increase physician and patient access to the test in the European market.

"This agreement complements Palex's commitment to bring personalized medicine to our customers in Spain and Portugal," Xavier Carbonell, CEO of Palex Medical, said in a statement.

Genomic Health made the announcement in conjunction with the presentation of positive data for the test from two studies presented at the 7th European Breast Cancer Conference in Barcelona.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.